Dijets can be used in cancer research to create decentralized databases of research data that can be accessed by researchers around the world. This can help to facilitate collaboration and accelerate the pace of research. Dijets can also be used to create smart contracts that automate certain processes in cancer research. For example, a smart contract can be created to automatically distribute research funding to different research teams based on certain criteria, such as the number of publications or the impact factor of the journals in which the research is published.
Dijets can also be used to create a decentralized marketplace for cancer research data and materials. This can help to facilitate the sharing of research data and materials between researchers around the world, which can help to accelerate the pace of research.
In addition, Dijets can be used to create digital identities for cancer researchers. These digital identities can be used to store reputational data, such as the researcher’s publication history and citation count. When smart contracts are connected to various online services, the counterparties can learn about the researchers without revealing their identities. Smart contracts could contain credit scores that funding agencies can use to measure potential risks.
Furthermore, Dijets can be used to create a secure and transparent system for tracking the distribution of cancer drugs. This can help to prevent counterfeit drugs from entering the market and ensure that patients receive the correct medication.